Skip to main content
. 2018 May 28;11:3185–3194. doi: 10.2147/OTT.S158104

Table 1.

Predictive lncRNAs involved in response to cisplatin

lncRNAs Role in response Targets Mechanisms Cancers Ref
AC023115.3 S miR-26a/GSK3β ceRNA Glioblastoma 76
AK022798 R MRP1, P-gp N/A Gastric cancer 39
AK126698 R Wnt/β-catenin N/A NSCLC 69
ANRIL R MDR1, MRP1 N/A Gastric cancer 41
ANRIL R let-7a N/A Nasopharyngeal carcinoma 50
CASC2 S miR-21/PTEN ceRNA Cervical cancer 80
ENST00000457645 S Bax, caspase-3 N/A Ovarian cancer 59
GAS5 S miR-21/PI3K/Akt ceRNA Cervical cancer 83
GAS5 S miR-21/PTEN ceRNA NSCLC 81
HOTAIR R NF-κB By decreasing Iκ-Bα Ovarian cancer 48
HOTAIR R p21Waf1/Cip1 N/A Lung adenocarcinoma 49
HOTAIR R Beclin-1, MDR, and P-gp N/A Endometrial cancer 74
HOTAIR R Klf4 N/A NSCLC 78
HOTTIP R Wnt/β-catenin N/A Osteosarcoma 71
H19 R NRF2 N/A Ovarian cancer 46
H19 R FAS, BAK, BAX N/A Lung adenocarcinoma 58
LINC00161 S miR-645/IFIT2 ceRNA Osteosarcoma 79
MEG3 S p53, β-catenin, survivin, Bcl-xl N/A Lung cancer 53, 54
MEG3 S miR-214 N/A Ovarian cancer 63
MEG3 S miR-21-5p/SOX7 ceRNA NSCLC 82
NEAT1 S CTR1 ceRNA Lung cancer 43
PDAM S p53, BCL2L1 N/A Glioma 51
PVT1 R MDR1, MRP, mTOR, HIF-1a N/A Gastric cancer 40
PVT1 R TGF-β1, p-Smad4, caspase-3 N/A Ovarian cancer 60
ROR R p53 N/A Nasopharyngeal carcinoma 52
SFTA1P S hnRNP-U-/ADD45A N/A LSCC 64
TRPM2-AS R p53-p66shc N/A NSCLC 56
UCA1 R miR-196a Affecting transcription by activating CREB Bladder cancer 61
UCA1 R Caspase-3, CDK2, surviving, p21 N/A Cervical cancer 62
UCA1 R Wnt/β-catenin N/A Bladder cancer 70
XIST R miR-17/ATG7 ceRNA NSCLC 75

Abbreviations: ABCB1, ATP-binding cassette subfamily B member 1; ABCC1, ATP-binding cassette subfamily C member 1; ABCG2, ATP-binding cassette subfamily G member 2; ceRNA, competing endogenous RNA; CREB, cAMP response element-binding protein; CTR1, copper transporter 1; lncRNAs, long non-coding RNAs; LSCC, lung squamous cell carcinoma; MDR1, multidrug-resistant protein; MRP1, multidrug-resistant-associated protein 1; N/A, not available; NEAT1, nuclear-enriched abundant transcript 1; NSCLC, non-small-cell lung cancer; P-gp, P-glycoprotein; R, resistance; Ref, reference; S, sensitivity.